Olema Pharmaceuticals, Inc. 10-Q

Item 5. Other Information. None. 100 Table of Contents Item 6. Exhibits. ​ ​ ​ ​ ​ ​ ​ ​ ​ Incorporated by Reference Exhibit Number Description Schedule Form File Number Exhibit Filing Date 3.1 Amended and Restated Certificate of Incorporation . 8-K 001-39712 3.1 11/23/2020 3.2 Amended and Restated Bylaws . 8-K 001-39712 3.1 12/16/2022 31.1* Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.2* Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. ​ ​ ​ ​ 32.1*# Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 101.INS* XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL Document ​ ​ ​ ​ 101.SCH* XBRL Taxonomy Extension Schema Document ​ ​ ​ ​ 101.CAL* XBRL Taxonomy Extension Calculation Linkbase Document ​ ​ ​ ​ 101.DEF* XBRL Taxonomy Extension Definition Linkbase Document ​ ​ ​ ​ 101.LAB* XBRL Taxonomy Extension Label Linkbase Document ​ ​ ​ ​ 101.PRE* XBRL Taxonomy Extension Presentation Linkbase Document ​ ​ ​ ​ 104 Cover Page Interactive Data File – The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document ​ ​ ​ ​ ​ ​ * Filed herewith. # The certifications attached as Exhibit 32.1 accompany this Quarterly Report on Form 10-Q pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed “filed” by the Registrant for purposes of Section 18 of the Exchange Act, and are not to be incorporated by reference into any of the Registrant’s filings under the Securities Act, irrespective of any general incorporation language contained in any such filing. ​ ​ 101 Table of Contents SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Olema Pharmaceuticals, Inc. Date: August 8, 2023 By: /s/ Sean Bohen, M.D., Ph.D. ​ ​ Sean Bohen, M.D., Ph.D. President and Chief Executive Officer ( Principal Executive Officer ) Olema Pharmaceuticals, Inc. Date: August 8, 2023 By: /s/ Shane Kovacs ​ ​ Shane Kovacs Chief Operating and Financial Officer ( Principal Financial Officer and Principal Accounting Officer ) ​ ​ ​ 102